Drugs for Neglected Diseases initiative - DNDi

Drugs for Neglected Diseases initiative - DNDi

DNDi is an international, not-for-profit research and development organization dedicated to discovering, developing, and delivering affordable and patient-friendly treatments for neglected patients worldwide. The organization focuses on researching new treatments for various neglected diseases such as Chagas disease, sleeping sickness, leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Collaborating with partners, DNDi is involved in over 40 projects and more than 20 new chemical entities, along with over 20 clinical trials.

Founded in 2003 as an initiative backed by Médecins Sans Frontières (MSF), the World Health Organization, and five international research institutions, DNDi aims to address the fatal imbalance in drug development for neglected patients. Based in Switzerland, the organization's mission aligns with the humanitarian spirit, striving to save millions of lives with its affordable medical solutions. Although specific details regarding last investment and investors are not available, the impact, reach, and altruistic nature of DNDi's endeavors present a compelling case for potential future investment or collaboration.